Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07687797

Partially Hydrolysed Whey Based Formula in Differentiation Between Non IgE Gastrointestinal Cow's Milk Protein Allergy and Milk Intolerance

Partially hydrolysed whey based formula in differentiation between non IgE gastrointestinal cow's milk protein allergy and milk intolerance

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

1 month–6 month

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 1-6 months of age
  • formula fed infants
  • CoMiSS score above 10
  • Repeated body mucoid stool

Exclusion criteria

  • IgE mediated disease
  • Skin allergy
  • Respiratory symptoms
  • Exclusive or mixed breast feeding

Treatment and study plan

partially hydrolysed whey based formula

Dietary Supplement

partially hydrolysed whey based formula

Amino acid based formula

Dietary Supplement

classic pathway of cow milk protein intolerance

Primary outcomes

  1. determining the frequency of cow milk intolerance diagnosis among patients suspected for cow milk protein allergy

    Time frame: 12 weeks

Study contacts

Contact information is provided by the study sponsor or research team.

Mostafa Elhodhod

CONTACT

[email protected]

+2010065541445

Sponsors and collaborators

Lead sponsor

Ain Shams University

Other

Registry information

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Jul 7, 2026
Registry last updated
Jul 7, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.